280 related articles for article (PubMed ID: 10706881)
1. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover.
Bahram F; von der Lehr N; Cetinkaya C; Larsson LG
Blood; 2000 Mar; 95(6):2104-10. PubMed ID: 10706881
[TBL] [Abstract][Full Text] [Related]
2. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.
Gregory MA; Hann SR
Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166
[TBL] [Abstract][Full Text] [Related]
3. c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.
Gavioli R; Frisan T; Vertuani S; Bornkamm GW; Masucci MG
Nat Cell Biol; 2001 Mar; 3(3):283-8. PubMed ID: 11231578
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies.
Dantuma NP; Masucci MG
Semin Cancer Biol; 2003 Feb; 13(1):69-76. PubMed ID: 12507558
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
Smith-Sørensen B; Hijmans EM; Beijersbergen RL; Bernards R
J Biol Chem; 1996 Mar; 271(10):5513-8. PubMed ID: 8621409
[TBL] [Abstract][Full Text] [Related]
6. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitylation and destruction of endogenous c-mycS by the proteasome: are myc boxes dispensable?
Chen L; Smith L; Accavitti-Loper MA; Omura S; Bingham Smith J
Arch Biochem Biophys; 2000 Feb; 374(2):306-12. PubMed ID: 10666312
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and an N-myc-independent decrease in Skp2.
Nakamura M; Matsuo T; Stauffer J; Neckers L; Thiele CJ
Cell Death Differ; 2003 Feb; 10(2):230-9. PubMed ID: 12700651
[TBL] [Abstract][Full Text] [Related]
9. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain.
Hoang AT; Lutterbach B; Lewis BC; Yano T; Chou TY; Barrett JF; Raffeld M; Hann SR; Dang CV
Mol Cell Biol; 1995 Aug; 15(8):4031-42. PubMed ID: 7623799
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
Diehl JA; Zindy F; Sherr CJ
Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
[TBL] [Abstract][Full Text] [Related]
11. Evidence for involvement of calpain in c-Myc proteolysis in vivo.
Small GW; Chou TY; Dang CV; Orlowski RZ
Arch Biochem Biophys; 2002 Apr; 400(2):151-61. PubMed ID: 12054425
[TBL] [Abstract][Full Text] [Related]
12. Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.
Aviel S; Winberg G; Massucci M; Ciechanover A
J Biol Chem; 2000 Aug; 275(31):23491-9. PubMed ID: 10807912
[TBL] [Abstract][Full Text] [Related]
13. B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation.
Gregory MA; Xiao Q; Cornwall GA; Lutterbach B; Hann SR
Oncogene; 2000 Oct; 19(42):4886-95. PubMed ID: 11039906
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
Orlowski RZ; Eswara JR; Lafond-Walker A; Grever MR; Orlowski M; Dang CV
Cancer Res; 1998 Oct; 58(19):4342-8. PubMed ID: 9766662
[TBL] [Abstract][Full Text] [Related]
15. Implication of the ubiquitin/proteasome system in Myc-regulated transcription.
von der Lehr N; Johansson S; Larsson LG
Cell Cycle; 2003; 2(5):403-7. PubMed ID: 12963825
[TBL] [Abstract][Full Text] [Related]
16. Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles.
Gavine PR; Neil JC; Crouch DH
Oncogene; 1999 Dec; 18(52):7552-8. PubMed ID: 10602514
[TBL] [Abstract][Full Text] [Related]
17. Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh.
Wall NR; Mohammad RM; Reddy KB; Al-Katib AM
Int J Mol Med; 2000 Feb; 5(2):165-71. PubMed ID: 10639596
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
[TBL] [Abstract][Full Text] [Related]
19. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor.
Niu H; Ye BH; Dalla-Favera R
Genes Dev; 1998 Jul; 12(13):1953-61. PubMed ID: 9649500
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
